0001035267-20-000028.txt : 20200205 0001035267-20-000028.hdr.sgml : 20200205 20200205212601 ACCESSION NUMBER: 0001035267-20-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200205 FILED AS OF DATE: 20200205 DATE AS OF CHANGE: 20200205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson Amal M CENTRAL INDEX KEY: 0001388397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30713 FILM NUMBER: 20580680 MAIL ADDRESS: STREET 1: C/O MELLANOX TECHNOLOGIES, INC. STREET 2: 350 OAKMEAD PARKWAY, SUITE 100 CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC CENTRAL INDEX KEY: 0001035267 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 770416458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 4085232100 MAIL ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-02-05 0 0001035267 INTUITIVE SURGICAL INC ISRG 0001388397 Johnson Amal M 1020 KIFER ROAD SUNNYVALE CA 94086 1 0 0 0 Common Stock 2020-02-05 4 M 0 4250 119.0633 A 13456 D Common Stock 2020-02-05 4 S 0 4250 577.4332 D 9206 D Non-Qualified Stock Option (right to buy) 119.0633 2020-02-05 4 M 0 4250 0.0 D 2021-04-21 Common Stock 4250 3000 D These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 15, 2020. The average selling price for the transaction was $577.433231. Shares sold at $574.381 - $574.951 = 500; shares sold at $575.05 - $575.79 = 1,059; shares sold at $576.40 - $576.449 = 557; shares sold at $577.958 - $578.82 = 358; shares sold at $579.09 - $579.882 = 1,495; shares sold at $580.6 - $581.36 = 281. Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. By: Lori Serrano For: Amal M. Johnson 2020-02-05